NextCure | PRE 14A:并购重组委托声明
NextCure | 8-K:重大事件
NextCure | 8-K:重大事件
NextCure | 10-K:2024财年年报
NextCure | SCHEDULE 13G/A:其他
NextCure | 3:首次持股声明-高管 Guha Udayan
NextCure | 4:持股变动声明-高管 Shaw Kevin G.
NextCure | 4:持股变动声明-高管 Mayer Timothy
NextCure | 8-K:重大事件
NextCure | 4:持股变动声明-高管 Richman Michael
NextCure | 4:持股变动声明-高管 Cobourn Steven P.
NextCure | 4:持股变动声明-高管 Kundu Sourav
NextCure | 4:持股变动声明-高管 Langermann Sol
NextCure | 8-K:重大事件
NextCure | 8-K:重大事件
NextCure | 8-K:重大事件
NextCure | SC 13G/A:超过5%持股股东披露文件(修正)-Logos Global Management LP(8.9%),Logos Global Management GP LLC(8.9%)等
NextCure | SC 13G/A:超过5%持股股东披露文件(修正)-Affinity Healthcare Fund, LP (EIN(8.22%),Affinity Asset Advisors, LLC (EIN(8.22%)
NextCure | 8-K:重大事件
NextCure | 10-Q:2024财年三季报